Scientific paper - Original scientific paper
Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis
Biochemia Medica, 33 (2023), 2; 020901. https://doi.org/10.11613/BM.2023.020901

Lucijanić, Marko; Krečak, Ivan; Sorić, Ena; Sabljić, Anica; Galušić, Davor; Holik, Hrvoje; Periša, Vlatka; Perić, Martina Morić; Zekanović, Ivan; Kušec, Rajko

Cite this document

Lucijanić, M., Krečak, I., Sorić, E., Sabljić, A., Galušić, D., Holik, H. ... Kušec, R. (2023). Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis. Biochemia Medica, 33. (2). doi: 10.11613/BM.2023.020901

Lucijanić, Marko, et al. "Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis." Biochemia Medica, vol. 33, no. 2, 2023. https://doi.org/10.11613/BM.2023.020901

Lucijanić, Marko, Ivan Krečak, Ena Sorić, Anica Sabljić, Davor Galušić, Hrvoje Holik, Vlatka Periša, Martina Morić Perić, Ivan Zekanović and Rajko Kušec. "Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis." Biochemia Medica 33, no. 2 (2023). https://doi.org/10.11613/BM.2023.020901

Lucijanić, M., et al. (2023) 'Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis', Biochemia Medica, 33(2). doi: 10.11613/BM.2023.020901

Lucijanić M, Krečak I, Sorić E, Sabljić A, Galušić D, Holik H, and sur.. Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis. Biochemia Medica [Internet]. 2023 [cited 2024 September 30];33(2). doi: 10.11613/BM.2023.020901

M. Lucijanić, et al., "Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis", Biochemia Medica, vol. 33, no. 2, 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:721932. [Accessed: 30 September 2024]

Please login to the repository to save this object to your list.